ABBOTT INDIA Latest Share Price (ABBOTINDIA)
TODAY IN ONE LINE
ABBOTINDIA is little changed at ₹26185.00 on light volume — a quiet consolidation day.
With a market cap of ₹55,719.18 Cr., it trades at a P/E of 34.22. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
ABBOTT INDIA flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●High Capital EfficiencyROCE of 42.6% indicating pricing power
- ●Strong Return on EquityHealthy ROE of 36.7%
- ●Healthy Operating MarginsOPM is structurally strong at 30.4%
- ●Steady Dividend YieldReliable 2.01% dividend yield
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
- ●Positive Free Cash FlowFCF has been positive for 3 consecutive years
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Sales ContractionQuarterly sales dropped 73.8% YoY
- ●Rising Receivables vs SalesReceivables grew 52.4% outpacing sales growth of 9.6%
Latest ABBOTT INDIA News
What changed recently?
Recent events, corporate actions, and announcements.
ABBOTT INDIA valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for ABBOTT INDIA, framed against the sector median so the premium or discount is obvious at a glance.
ABBOTT INDIA trades at a P/E of 34.22× and P/B of 11.57×, against the Healthcare sector median P/E of 40.55×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
ABBOTT INDIA technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for ABBOTT INDIA — derived from the latest tape, not yesterday's close.
ABBOTT INDIA last traded at ₹26,185 with an intraday range of ₹25,830–₹26,280 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹26185.00| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 27266.67 | +1081.67 | +4.13% |
| R3 | 26816.67 | +631.67 | +2.41% |
| R2 | 26548.33 | +363.33 | +1.39% |
| R1 | 26366.67 | +181.67 | +0.69% |
| PIVOT | 26098.33 | -86.67 | -0.33% |
| CURRENT | 26185.00 | — | — |
| S1 | 25916.67 | -268.33 | -1.02% |
| S2 | 25648.33 | -536.67 | -2.05% |
| S3 | 25466.67 | -718.33 | -2.74% |
| S4 | 25016.67 | -1168.33 | -4.46% |
ABBOTINDIA is trading Above CPR, indicating Bullishness
CPR is Average
Day's range: ₹25915–₹26145
Trading Inside opening range
ABBOTT INDIA financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for ABBOTT INDIA — consolidated or standalone — with margins, YoY growth and key ratios inline.
ABBOTT INDIA reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹55,719.18 Cr. and reported EPS of ₹760.24.
ABBOTT INDIA segment analysis : revenue and profit mix.
Disclosed business segments at ABBOTT INDIA with their share of revenue and profit, switchable between consolidated and standalone reporting.
ABBOTT INDIA discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for ABBOTT INDIA.
Our AI distills the core fundamental drivers supporting ABBOTT INDIA, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
ABBOTT INDIA's investment case rests on 0 positive markers and 1 flagged concerns drawn from the latest reported filings.
What you're getting.
No strengths or opportunities on record.
Key Risks.
SWOT generation temporarily unavailable due to model error. Bedrock invocation timeout
Flip Conditions.
Valuation risk. a P/E above 44 (~1.1× the sector multiple of 40.5) would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Return-quality risk. ROE below 32% would indicate weaker capital compounding.
Income thesis breaks if the dividend is cut or yield falls below 1.00%.
ABBOTT INDIA peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — ABBOTT INDIA is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
ABBOTT INDIA chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for ABBOTT INDIA — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
ABBOTT INDIA delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for ABBOTT INDIA over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in ABBOTT INDIA stood at 53.5% of traded volume, against a 20-day average of 55.7%.
ABBOTT INDIA announcements: results, concalls, ratings, M&A.
Filings ABBOTT INDIA sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
ABBOTT INDIA files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 62 documents below.
Company Update
Resignation of Company Secretary and Compliance Officer of the Company.
Company Update
Communication to Shareholders - Intimation about Tax Deduction at Source on Dividend.
Company Update
Newspaper Advertisement - Special Window for Transfer and Dematerialization of Physical Securities.
Investor decks & rating reports.
ABBOTT INDIA dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue ABBOTT INDIA has declared, sequenced by announce and record date.
ABBOTT INDIA corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About ABBOTT INDIA: business, sector, key facts.
What ABBOTT INDIA does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
ABBOTT INDIA operates in the Pharmaceuticals industry under the Healthcare sector, listed as NSE: ABBOTINDIA, BSE: 500488.
Abbott India Limited is a prominent pharmaceutical company operating within India. Its business model centers on the research, development, manufacturing, and distribution of a wide range of pharmaceutical products catering to diverse therapeutic areas. The company's portfolio is extensive and addresses significant unmet medical needs across the Indian population.
A key aspect of Abbott India's business is its focus on specific therapeutic areas. These include gastroenterology, women's health, metabolic disorders, central nervous system conditions, and vaccines. The company also offers products for multispecialty needs, encompassing conditions such as insomnia, vitamin D deficiency, preterm labor, and pain management. This diversified approach allows Abbott India to serve a broad spectrum of patients and healthcare providers.
Further diversification is evident in Abbott India's product categories. The company manufactures and markets anti-infective agents, cardio-diabetological medications, hepatology products, hormone therapies, neuro-psychiatric medications, hepatic treatments, and products categorized as 'gennext' (likely referring to newer generation pharmaceuticals). A consumer care segment also forms part of their offerings, indicating a broader reach beyond purely prescription-based pharmaceuticals.
Abbott India's long history, dating back to 1910, speaks to its established presence and experience within the Indian pharmaceutical market. Headquartered in Mumbai, the company operates as a subsidiary of Abbott Capital India Limited, benefiting from the resources and expertise of its parent company. This structural positioning likely supports Abbott India's continued growth and market competitiveness.
In summary, Abbott India's business is characterized by its diversified pharmaceutical portfolio addressing major therapeutic areas and diverse patient needs. The company's long operational history, strategic focus, and parent company support contribute to its significant position within the Indian pharmaceutical landscape. Its range extends from prescription-based treatments to consumer healthcare products, allowing it to cater to a wide audience.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- 3B BLACKBIO DX (3BBLACKBIO) Share PricePeer
- ACUTAAS CHEMICALS (ACUTAAS) Share PricePeer
- ANLON HEALTHCARE (AHCL) Share PricePeer
- AMANTA (AMANTA) Share PricePeer
- AMBALALSA (AMBALALSA) Share PricePeer
- Stocks near 52-week low (reversal watch)Screener
- Reversal Hunter strategy playbookStrategy
- Top quality scorecard stocksScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about ABBOTT INDIA (ABBOTINDIA).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of ABBOTT INDIA (ABBOTINDIA)?
The current share price of ABBOTT INDIA (ABBOTINDIA) is ₹26,185.00. Today, the stock has gained by ₹60.00 (0.23%), trading in a range of ₹25,830.00 to ₹26,280.00. The stock opened at ₹26,125.00 with a trading volume of 1,794 shares.
02Is ABBOTT INDIA stock a good investment for long-term?
ABBOTT INDIA can be considered for long-term investment based on several factors. The company has a market capitalization of ₹55,719.18 Cr., P/E ratio of 34.22, ROE of 36.66%, and ROCE of 42.6%. The dividend yield stands at 2.01%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of ABBOTT INDIA stock?
The 52-week high price of ABBOTT INDIA (ABBOTINDIA) is ₹31,355.00, while the 52-week low is ₹25,135.00. Currently trading at ₹26,185.00, the stock is 4.18% above its 52-week low and 16.49% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy ABBOTT INDIA stock at the current price?
Whether to buy ABBOTT INDIA stock at ₹26,185.00 depends on multiple factors. The stock is currently trading with a P/E ratio of 34.22 and P/B ratio of 11.57. Today's performance shows a gain of 0.23%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of ABBOTT INDIA and when is the next dividend?
ABBOTT INDIA offers a dividend yield of 2.01%, which means for every ₹100 invested at the current price of ₹26,185.00, you can expect to receive approximately ₹2.01 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of ABBOTT INDIA?
ABBOTT INDIA's key financial metrics include: P/E Ratio: 34.22, P/B Ratio: 11.57, ROE: 36.66%, ROCE: 42.6%, Dividend Yield: 2.01%, EPS: ₹760.24, Book Value: ₹2,246.75, and Debt-to-Equity: 0. The company's market cap stands at ₹55,719.18 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is ABBOTT INDIA stock performing today in the market?
ABBOTT INDIA stock opened at ₹26,125.00 and is currently trading at ₹26,185.00, showing a gain of ₹60.00 (0.23%). The intraday high is ₹26,280.00 and low is ₹25,830.00. The trading volume stands at 1,794 shares, indicating moderate market participation today.
08What is the P/E ratio of ABBOTT INDIA and what does it indicate?
ABBOTT INDIA has a Price-to-Earnings (P/E) ratio of 34.22, which means investors are willing to pay 34.22 for every ₹1 of earnings. With an EPS of ₹760.24, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about ABBOTT INDIA (ABBOTINDIA) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.